↓ Skip to main content

Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months

Overview of attention for article published in The Journal of Headache and Pain, October 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
4 news outlets
twitter
14 X users

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months
Published in
The Journal of Headache and Pain, October 2021
DOI 10.1186/s10194-021-01328-1
Pubmed ID
Authors

Edoardo Caronna, Victor José Gallardo, Alicia Alpuente, Marta Torres-Ferrus, Patricia Pozo-Rosich

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 13%
Other 5 10%
Researcher 5 10%
Student > Postgraduate 5 10%
Student > Master 3 6%
Other 3 6%
Unknown 21 44%
Readers by discipline Count As %
Medicine and Dentistry 12 25%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Neuroscience 5 10%
Agricultural and Biological Sciences 1 2%
Computer Science 1 2%
Other 1 2%
Unknown 23 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 January 2023.
All research outputs
#954,380
of 25,282,542 outputs
Outputs from The Journal of Headache and Pain
#107
of 1,519 outputs
Outputs of similar age
#22,150
of 429,097 outputs
Outputs of similar age from The Journal of Headache and Pain
#5
of 35 outputs
Altmetric has tracked 25,282,542 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,519 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.6. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,097 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.